DK1572229T3 - Stabilt terapeutisk fibrinogen - Google Patents

Stabilt terapeutisk fibrinogen

Info

Publication number
DK1572229T3
DK1572229T3 DK03781990.1T DK03781990T DK1572229T3 DK 1572229 T3 DK1572229 T3 DK 1572229T3 DK 03781990 T DK03781990 T DK 03781990T DK 1572229 T3 DK1572229 T3 DK 1572229T3
Authority
DK
Denmark
Prior art keywords
stable therapeutic
fibrinogen
therapeutic fibrinogen
stable
therapeutic
Prior art date
Application number
DK03781990.1T
Other languages
English (en)
Inventor
Johann Eibl
Original Assignee
Bio & Bio Licensing Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32512947&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1572229(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bio & Bio Licensing Sa filed Critical Bio & Bio Licensing Sa
Application granted granted Critical
Publication of DK1572229T3 publication Critical patent/DK1572229T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK03781990.1T 2002-12-18 2003-12-18 Stabilt terapeutisk fibrinogen DK1572229T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0189002A AT501088A2 (de) 2002-12-18 2002-12-18 Stabile therapeutische proteine
PCT/AT2003/000374 WO2004054607A2 (de) 2002-12-18 2003-12-18 Stabile therapeutische proteine

Publications (1)

Publication Number Publication Date
DK1572229T3 true DK1572229T3 (da) 2014-06-23

Family

ID=32512947

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03781990.1T DK1572229T3 (da) 2002-12-18 2003-12-18 Stabilt terapeutisk fibrinogen

Country Status (7)

Country Link
US (2) US7795399B2 (da)
EP (2) EP1572229B1 (da)
AT (1) AT501088A2 (da)
AU (1) AU2003289742A1 (da)
DK (1) DK1572229T3 (da)
ES (1) ES2476815T3 (da)
WO (1) WO2004054607A2 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT407484B (de) * 1997-11-12 2001-03-26 Bio Prod & Bio Eng Ag Arzneimittel zur förderung der wundheilung
IL162239A0 (en) 2001-12-21 2005-11-20 Novo Nordisk Healthcare Ag Liquid composition of factor vii polypeptides
US20040009918A1 (en) * 2002-05-03 2004-01-15 Hanne Nedergaard Stabilised solid compositions of modified factor VII
EP2283856B1 (en) 2002-06-21 2017-09-20 Novo Nordisk Health Care AG Stabilised solid compositions of factor VIIa polypeptides
AT501088A2 (de) * 2002-12-18 2006-06-15 Bio Prod & Bio Eng Ag Stabile therapeutische proteine
US7897734B2 (en) 2003-03-26 2011-03-01 Novo Nordisk Healthcare Ag Method for the production of proteins
CA2525224A1 (en) 2003-05-23 2004-12-02 Michael Bech Jensen Protein stabilization in solution
ATE547114T1 (de) 2003-06-25 2012-03-15 Novo Nordisk Healthcare Ag Flüssige zusammensetzungen von factor vii polypeptiden
ES2335994T3 (es) * 2003-07-01 2010-04-07 Novo Nordisk Health Care Ag Composicion farmaceutica liquida, acuosa de polipeptidos factor vii.
ES2574581T3 (es) 2003-08-14 2016-06-20 Novo Nordisk Health Care Ag Composición farmacéutica líquida acuosa de polipéptidos de tipo Factor VII
EP2298287B1 (en) 2003-12-19 2018-04-11 Novo Nordisk Health Care AG Stabilised compositions of factor VII polypeptides
TWI270375B (en) * 2004-06-29 2007-01-11 Cheng-Yao Su A method for preserving platelets outside a living body
US7659052B2 (en) * 2004-06-29 2010-02-09 Cheng Yao Su Medium comprising cryoprecipitate and method for preserving platelets, red blood cells and other cells without a nucleus
FR2887883B1 (fr) 2005-06-29 2007-08-31 Lab Francais Du Fractionnement Procede de separation des proteines fibrinogene, facteur xiii et colle biologique d'une fraction plasmatique solubilisee et de preparation de concentres lyophilises desdites proteines
EP1935429A1 (en) 2006-12-22 2008-06-25 CSL Behring GmbH Synergistic therapeutic use of prothrombin complex concentrates with FVIII concentrates
EP2293776B8 (de) 2008-06-23 2016-05-11 Bio-Products & Bio-Engineering Aktiengesellschaft Lagerstabiles, funktionell intaktes virus-inaktiviertes fibrinogen
EP2305289A1 (en) * 2009-09-16 2011-04-06 Bio-Products & Bio-Engineering Aktiengesellschaft Medicinal products for the treatment of blood coagulation disorders
US9371355B2 (en) 2010-09-20 2016-06-21 Octapharma Ag Process for production of fibrinogen
RU2663792C2 (ru) 2012-03-13 2018-08-09 Октафарма Аг Способ очистки фибриногена, продукт фибриногена и средство для очистки или производства продукта фибриногена
TWI731108B (zh) * 2016-06-24 2021-06-21 徐家祥 具有止血功能的醫藥組合物

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT359646B (de) * 1979-04-19 1980-11-25 Immuno Ag Verfahren zur herstellung von nebenwirkungs- freien plasmafraktionen
DE2916711A1 (de) * 1979-04-25 1980-11-06 Behringwerke Ag Blutgerinnungsfaktoren und verfahren zu ihrer herstellung
US4440679A (en) * 1980-03-05 1984-04-03 Cutter Laboratories, Inc. Pasteurized therapeutically active protein compositions
US4348384A (en) * 1980-10-17 1982-09-07 Dainippon Pharmaceutical Co., Ltd. Pharmaceutical composition for oral administration containing coagulation factor VIII or IX
US5614500A (en) * 1983-03-04 1997-03-25 The Scripps Research Institute Compositions containing highly purified factor IX proteins prepared by immunoaffinity chromatography
US4710381A (en) 1984-05-22 1987-12-01 The Blood Center Of Southeastern Wisconsin Method for maintaining intact, non-degraded factor VIII/von-Willebrand factor during blood processing
US5149787A (en) 1984-05-22 1992-09-22 The Blood Center Research Foundation Method for maintaining intact, non-degraded factor VIII/von-Willebrand factor during blood processing
AT391808B (de) * 1986-11-03 1990-12-10 Immuno Ag Verfahren zur herstellung einer faktor viii (ahf)-haeltigen fraktion
GB8628108D0 (en) * 1986-11-25 1986-12-31 London Biotechnology Ltd Riboflavin-linked assay
DE3640513A1 (de) * 1986-11-27 1988-06-09 Biotest Pharma Gmbh Verfahren zur herstellung eines virussicheren, lagerstabilen und intravenoes vertraeglichen immunglobulin-g-praeparates
US5175087A (en) * 1987-07-06 1992-12-29 Biopool International, Inc. Method of performing tissue plasminogen activator assay
EP0317376B2 (fr) * 1987-10-23 1996-04-03 Centre Regional De Transfusion Sanguine De Lille Préparation de concentré de facteur IX humain de haute pureté et d'autres protéines plasmatiques
ATE170982T1 (de) * 1990-02-14 1998-09-15 Pentapharm Ag Inhibitoren zur antikoagulierenden vorbehandung von blutproben
JP2758703B2 (ja) * 1990-07-31 1998-05-28 日本電気株式会社 音声合成器
DE69229272T2 (de) * 1991-09-05 2000-02-03 Baxter International Inc., Deerfield Topischer fibrinogenkomplex
US5278289A (en) * 1991-11-12 1994-01-11 Johnson Alan J Antihemophilic factor stabilization
US5645540A (en) * 1994-10-11 1997-07-08 Stryker Corporation Blood conservation system
US5736364A (en) * 1995-12-04 1998-04-07 Genentech, Inc. Factor viia inhibitors
US5804400A (en) * 1996-02-05 1998-09-08 Igen International, Inc. Electrochemiluminescent assay
JPH09286797A (ja) 1996-04-18 1997-11-04 Green Cross Corp:The ヘパリンコファクターｉｉ及びその精製方法
AT403989B (de) * 1996-09-16 1998-07-27 Immuno Ag Verfahren zur herstellung eines plasmaprotein-hältigen arzneimittels
DE10012732A1 (de) * 2000-03-18 2001-09-20 Aventis Behring Gmbh Thrombin-Zubereitungen und Verfahren zu ihrer Herstellung
IL136552A (en) * 2000-06-05 2005-05-17 Omrix Biopharmaceuticals Ltd Method for the inactivation of viruses by a solvent - detergent combination and by nanofiltration
DE10211632A1 (de) * 2002-03-15 2003-10-09 Aventis Behring Gmbh Verfahren zur Abtrennung von Viren aus einer Proteinlösung durch Nanofiltration
AT501088A2 (de) * 2002-12-18 2006-06-15 Bio Prod & Bio Eng Ag Stabile therapeutische proteine

Also Published As

Publication number Publication date
WO2004054607A3 (de) 2004-10-07
EP1572229A2 (de) 2005-09-14
WO2004054607A2 (de) 2004-07-01
AU2003289742A1 (en) 2004-07-09
AT501088A2 (de) 2006-06-15
US20110009324A1 (en) 2011-01-13
US20060009376A1 (en) 2006-01-12
US7795399B2 (en) 2010-09-14
EP2292255A2 (de) 2011-03-09
ES2476815T3 (es) 2014-07-15
EP2292255A3 (de) 2011-06-22
EP1572229B1 (de) 2014-04-30

Similar Documents

Publication Publication Date Title
NO20052914D0 (no) Terapeutiske forbindelser
DE60336213D1 (de) Chirurgisches klammergerät
DE60321742D1 (de) Schuhsohle
NO20033203L (no) Terapeutiske heterocykliske forbindelser
NO20044046L (no) Substituerte hydroksyetylaminer
DK1572229T3 (da) Stabilt terapeutisk fibrinogen
DE60326590D1 (de) Tend lamotrigin
NO20050689L (no) Terapeutisk anvendelse
NO20033205D0 (no) Terapeutiske kromanforbindelser
DE50310014D1 (de) Mähbalken
DK1597171T3 (da) Terapeutisk mikroskum
ATE496887T1 (de) Substituierte 5-aminomethyl-1h-pyrrol-2-carbons ureamide
DE50303208D1 (de) Osteosyntheseeinrichtung
DE60219211D1 (de) Sterilisator
DE50302582D1 (de) Schnapp-Kugelzapfen
DE60327150D1 (de) Nadelsatz
ITMI20021327A1 (it) Nuove ossialchilpiperazine
FR2839258B1 (fr) Deambulateur-siege
DE50306228D1 (de) Substituierte benzdioxepine
NL300932I2 (nl) ocrelizumab
FI20021817A0 (fi) Kanyyli
SE0203826D0 (sv) Therapeutic agents
SE0200450D0 (sv) Therapeutic agents
UA6623S (uk) Шприц
FIU20020195U0 (fi) Sauna-alusta